Neuroimmunomodulation
Original Paper
The Reductions in Sweetened Milk Intake Induced by Interleukin-1 and Endotoxin Are Not Prevented by Chronic Antidepressant TreatmentDunn A.J. · Swiergiel A.H.Department of Pharmacology and Therapeutics, Louisiana State University Health Sciences Center, Shreveport, La., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: December 13, 2001
Issue release date: December 2001
Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 0
ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)
For additional information: https://www.karger.com/NIM
Abstract
Administration of interleukin-1 (IL-1) and endotoxin (lipopolysaccharide, LPS) to rodents can decrease food intake, a behavioral response resembling the diminution of appetite observed in human depression. IL-1 and LPS are known to affect cerebral neurotransmission involving norepinephrine and serotonin, both of which have been implicated in feeding behavior and in the pharmacotherapy of depression in man. The ability of chronic antidepressant treatment to attenuate LPS-induced depressed feeding in rats has been cited as evidence that cytokines may be involved in human depression. Thus, we studied the effects of chronic treatment with the tricyclic antidepressant, imipramine, and the novel antidepressant, venlafaxine, on the sweetened milk intake challenged with intraperitoneally injected IL-1β and LPS. Chronic (from 2 to 8 weeks) treatment of the mice with imipramine (10 mg/kg once or twice daily) or venlafaxine (10 and 20 mg/kg/day) did not significantly alter the decreases in milk intake in response to mIL-1β or LPS. In some experiments, chronic imipramine slightly decreased body weight and slightly increased milk intake, but not food pellet intake. Venlafaxine had none of these effects. Analysis of variance did not indicate any significant interactions between the antidepressant and IL-1 or LPS treatments. These results indicate that chronic treatment with antidepressants does not significantly alter the responses to IL-1 or LPS in the mouse sweetened milk model of sickness behavior.
© 2001 S. Karger AG, Basel
Related Articles:
References
- Hart BL: Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988;12:123–137.
- Kent S, Bluthé R-M, Kelley KW, Dantzer R: Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992;13:24–28.
-
Dantzer R, Bluthé R-M, Castanon N, Chauvet N, Capuron L, Goodall G, Kelley KW, Konsman J-P, Layé S, Parnet P, Pousset F: Cytokine effects on behavior; in Ader R, Felten D, Cohen N (eds): Psychoneuroimmunology. San Diego, Academic Press, 2001, pp 703–727.
- Yirmiya R: Endotoxin produces a depressive-like episode in rats. Brain Res 1996;711:163–174.
-
Dantzer R, Wollman EE, Vitkovic L, Yirmiya R: Cytokines, stress, and depression; in Dantzer R, Wollman EE, Yirmiya R (eds): Cytokines, Stress, and Depression. New York, Kluwer Academic/Plenum Publishers, 1999, pp 317–329.
- Charlton BG: The malaise theory of depression: Major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypotheses 2000;54:126–130.
-
de Beaurepaire R: Dépression et cytokines. Deuxième partie: une analyse critique de la théorie cytokinergique de la dépression. Dépression 1999;17:40–52.
-
Dunn AJ: Effects of cytokines and infections on brain neurochemistry; in Ader R, Felten DL, Cohen N (eds): Psychoneuroimmunology. San Diego, Academic Press, 2001, pp 649–666.
- Swiergiel AH, Burunda T, Patterson B, Dunn AJ: Endotoxin- and interleukin-1-induced hypophagia are not affected by noradrenergic, dopaminergic, histaminergic and muscarinic antagonists. Pharmacol Biochem Behav 1999;63:629–637.
- Swiergiel AH, Dunn AJ: Lack of evidence for a role of serotonin in interleukin-1-induced hypophagia. Pharmacol Biochem Behav 2000;65:531–537.
- Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M, Weihe E, Weidenfeld J: Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 2001;24:531–544.
- Castanon N, Bluthé R-M, Dantzer R: Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat. Psychopharmacology 2001;154:50–60.
- Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE: Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci 1999;65:1773–1786.
- Swiergiel AH, Smagin GN, Dunn AJ: Influenza virus infection of mice induces anorexia: Comparison with endotoxin and interleukin-1 and the effects of indomethacin. Pharmacol Biochem Behav 1997;57:389–396.
- Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ: The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: Effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res 1997;776:96–104.
- Langhans W, Savoldelli D, Weingarten S: Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1β. Physiol Behav 1993;53:643–649.
- Weingarten HP: Cytokines and food intake: The relevance of the immune system to the student of ingestive behavior. Neurosci Biobehav Rev 1996;20:163–170.
- McCarthy DO, Kluger MJ, Vander AJ: Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats. Physiol Behav 1986;36:745–749.
-
Yirmiya R, Morag M, Riechenberg A, Barak O, Pollak Y, Avitsur R, Kuhn M, Schuld A, Kraus T, Haak M, Ovadia H, Weidenfeld J, Morag A, Pollmächer T: Illness, cytokines and depression. Neuroimmunomodulation 1999;6:404–405.
-
Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R, Barak O, Reichenberg A, Cohen E, Shavit Y, Ovadia H: Cytokines, ‘Depression due to a general medical condition’ and antidepressant drugs; in Dantzer R, Wollman EE, Yirmiya R (eds): Cytokines, Stress, and Depression. New York, Kluwer Academic/Plenum Publishers, 1999, pp 283–316.
- Dantzer R: Cytokine-induced sickness behavior: Where do we stand? Brain Behav Immun 2001;15:7–24.
-
Larson SJ, Romanoff RL, Dunn AJ, Glowa JR: Effects of interleukin-1β on food-maintained behavior in the mouse. Brain Behav Immun, in press.
Article / Publication Details
Published online: December 13, 2001
Issue release date: December 2001
Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 0
ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)
For additional information: https://www.karger.com/NIM
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
